Skip to main content
Erschienen in: Calcified Tissue International 1/2015

01.07.2015 | Original Research

The Relationship of Bone Mineral Density to Oxidant/Antioxidant Status and Inflammatory and Bone Turnover Markers in a Multicenter Cross-Sectional Study of Young Men with Ankylosing Spondylitis

verfasst von: Le Wang, Liangbin Gao, Dan Jin, Peng Wang, Bo Yang, Wen Deng, Zhongyu Xie, Yong Tang, Yanfeng Wu, Huiyong Shen

Erschienen in: Calcified Tissue International | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Low bone mineral density (BMD) is an important complication of ankylosing spondylitis (AS) that seriously affects men and their quality of life, even in young patients. However, the relationships among redox; levels of bone turnover markers (BTMs), inflammatory markers and disease activity; and low BMD in AS require clarification. We recruited 102 men aged 30–39 year with AS and 102 healthy, sex- and age-matched controls for this cross-sectional study. The subjects were analyzed for lumbar spine and femoral neck BMD by dual-energy X-ray absorptiometry. Significantly lower BMD and corresponding T-scores were observed in the AS patients compared with the controls (P < 0.05). The oxidant biomarker and antioxidant levels were significantly (P < 0.05) higher and lower, respectively, in the AS subjects compared with the controls, and the bone resorption and inflammatory marker levels were higher (P < 0.05). In subgroup analyses, the patients with osteoporosis or active disease had the highest levels of oxidant biomarkers (P < 0.05). Furthermore, the BMD T-scores in AS were found to be negatively correlated with oxidative status (P < 0.05). Multivariate binary logistic analysis showed that low BMD in the AS patients was associated with higher levels of advanced oxidation protein products, malondialdehyde and C-terminal telopeptide of type I collagen; lower levels of glutathione peroxidase; and higher scores of a bath ankylosing spondylitis metrology index. In conclusion, imbalanced redox was independently associated with low BMD in young men with AS and may play an important role in the pathogenesis of AS-related low BMD.
Literatur
2.
Zurück zum Zitat Burgos-Vargas R (2013) Spondyloarthritis: from undifferentiated SpA to ankylosing spondylitis. Nat Rev Rheumatol 9:639–641PubMedCrossRef Burgos-Vargas R (2013) Spondyloarthritis: from undifferentiated SpA to ankylosing spondylitis. Nat Rev Rheumatol 9:639–641PubMedCrossRef
3.
Zurück zum Zitat Magrey M, Khan MA (2010) Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 12:332–336PubMedCrossRef Magrey M, Khan MA (2010) Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 12:332–336PubMedCrossRef
4.
Zurück zum Zitat Klingberg E, Geijer M, Göthlin J, Mellström D, Lorentzon M, Hilme E, Hedberg M, Carlsten H, Forsblad-D’Elia H (2012) Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton. J Rheumatol 39:1987–1995PubMedCrossRef Klingberg E, Geijer M, Göthlin J, Mellström D, Lorentzon M, Hilme E, Hedberg M, Carlsten H, Forsblad-D’Elia H (2012) Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton. J Rheumatol 39:1987–1995PubMedCrossRef
5.
Zurück zum Zitat van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, Dijkmans BA, Heymans MW, Lems WF (2012) High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int 23:1683–1690PubMedCrossRef van der Weijden MA, van der Horst-Bruinsma IE, van Denderen JC, Dijkmans BA, Heymans MW, Lems WF (2012) High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int 23:1683–1690PubMedCrossRef
6.
Zurück zum Zitat Ulu MA, Çevik R, Dilek B (2013) Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis. Rheumatol Int 33:1705–1711PubMedCrossRef Ulu MA, Çevik R, Dilek B (2013) Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis. Rheumatol Int 33:1705–1711PubMedCrossRef
7.
Zurück zum Zitat Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH (2011) The change of bone mineral density according to treatment agents in subjects with ankylosing spondylitis. Joint Bone Spine 78:188–193PubMedCrossRef Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH (2011) The change of bone mineral density according to treatment agents in subjects with ankylosing spondylitis. Joint Bone Spine 78:188–193PubMedCrossRef
8.
Zurück zum Zitat Korczowska I, Przepiera-Bedzak H, Brzosko M, Lacki JK, Trefler J, Hrycaj P (2011) Bone tissue metabolism in men with ankylosing spondylitis. Adv Med Sci 56:264–269PubMedCrossRef Korczowska I, Przepiera-Bedzak H, Brzosko M, Lacki JK, Trefler J, Hrycaj P (2011) Bone tissue metabolism in men with ankylosing spondylitis. Adv Med Sci 56:264–269PubMedCrossRef
9.
Zurück zum Zitat Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004PubMedCrossRef Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004PubMedCrossRef
10.
Zurück zum Zitat Kim HR, Lee SH, Kim HY (2006) Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in subjects with ankylosing spondylitis (as). Rheumatology (Oxford) 45:1197–1200CrossRef Kim HR, Lee SH, Kim HY (2006) Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in subjects with ankylosing spondylitis (as). Rheumatology (Oxford) 45:1197–1200CrossRef
11.
Zurück zum Zitat Couto D, Ribeiro D, Freitas M, Gomes A, Lima JL, Fernandes E (2010) Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine. Redox Rep 15:259–267PubMedCrossRef Couto D, Ribeiro D, Freitas M, Gomes A, Lima JL, Fernandes E (2010) Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine. Redox Rep 15:259–267PubMedCrossRef
12.
Zurück zum Zitat Miyamoto G, Zahid N, Uetrecht JP (1997) Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem Res Toxicol 10:414–419PubMedCrossRef Miyamoto G, Zahid N, Uetrecht JP (1997) Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem Res Toxicol 10:414–419PubMedCrossRef
13.
Zurück zum Zitat Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in subjects with ankylosing spondylitis. Rheumatol Int 24:80–83PubMedCrossRef Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in subjects with ankylosing spondylitis. Rheumatol Int 24:80–83PubMedCrossRef
14.
Zurück zum Zitat Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M (2004) Protein oxidation status in subjects with ankylosing spondylitis. Rheumatology (Oxford) 43:1235–1239CrossRef Yazici C, Kose K, Calis M, Kuzuguden S, Kirnap M (2004) Protein oxidation status in subjects with ankylosing spondylitis. Rheumatology (Oxford) 43:1235–1239CrossRef
15.
Zurück zum Zitat Walwadkar SD, Suryakar AN, Katkam RV, Kumbar KM, Ankush RD (2006) Oxidative stress and calcium-phosphorus levels in Rheumatoid arthritis. Indian J Clin Biochem 21(2):134–137PubMedCentralPubMedCrossRef Walwadkar SD, Suryakar AN, Katkam RV, Kumbar KM, Ankush RD (2006) Oxidative stress and calcium-phosphorus levels in Rheumatoid arthritis. Indian J Clin Biochem 21(2):134–137PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat vinh quốc Luong K, Nguyễn LT (2012) The beneficial role of vitamin D in systemic lupus erythematosus (SLE). Clin Rheumatol 31(10):1423–1435PubMedCrossRef vinh quốc Luong K, Nguyễn LT (2012) The beneficial role of vitamin D in systemic lupus erythematosus (SLE). Clin Rheumatol 31(10):1423–1435PubMedCrossRef
17.
Zurück zum Zitat Kozaci LD, Sari I, Alacacioglu A, Akar S, Akkoc N (2010) Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor. Mod Rheumatol 20:34–39PubMedCrossRef Kozaci LD, Sari I, Alacacioglu A, Akar S, Akkoc N (2010) Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor. Mod Rheumatol 20:34–39PubMedCrossRef
18.
Zurück zum Zitat Stanek A, Cieślar G, Romuk E, Kasperczyk S, Sieroń-Stołtny K, Birkner E, Sieroń A (2010) Decrease in antioxidant status of plasma and erythrocytes from subjects with ankylosing spondylitis. Clin Biochem 43:566–570PubMedCrossRef Stanek A, Cieślar G, Romuk E, Kasperczyk S, Sieroń-Stołtny K, Birkner E, Sieroń A (2010) Decrease in antioxidant status of plasma and erythrocytes from subjects with ankylosing spondylitis. Clin Biochem 43:566–570PubMedCrossRef
19.
Zurück zum Zitat Mlakar SJ, Osredkar J, Prezelj J, Marc J (2012) Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women. Menopause 19:368–376PubMedCrossRef Mlakar SJ, Osredkar J, Prezelj J, Marc J (2012) Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women. Menopause 19:368–376PubMedCrossRef
20.
Zurück zum Zitat Kuyumcu ME, Yesil Y, Oztürk ZA, Cınar E, Kızılarslanoglu C, Halil M, Ulger Z, Yesil NK, Cankurtaran M, Arıoğul S (2012) The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch Gerontol Geriat 55:739–743CrossRef Kuyumcu ME, Yesil Y, Oztürk ZA, Cınar E, Kızılarslanoglu C, Halil M, Ulger Z, Yesil NK, Cankurtaran M, Arıoğul S (2012) The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch Gerontol Geriat 55:739–743CrossRef
21.
Zurück zum Zitat Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z (2007) Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 38:196–205PubMedCrossRef Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z (2007) Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 38:196–205PubMedCrossRef
22.
Zurück zum Zitat Kamen DL, Alele JD (2010) Skeletal manifestations of systemic autoimmune diseases. Curr Opin Endocrinol Diabetes Obes 17(6):540–545PubMedCrossRef Kamen DL, Alele JD (2010) Skeletal manifestations of systemic autoimmune diseases. Curr Opin Endocrinol Diabetes Obes 17(6):540–545PubMedCrossRef
23.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed
24.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21:1694–1698PubMed Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21:1694–1698PubMed
25.
Zurück zum Zitat Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285PubMed
26.
Zurück zum Zitat Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313PubMedCrossRef Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313PubMedCrossRef
27.
Zurück zum Zitat Anderstam B, Ann-Christin BH, Valli A, Stenvinkel P, Lindholm B, Suliman ME (2008) Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta 393:114–118PubMedCrossRef Anderstam B, Ann-Christin BH, Valli A, Stenvinkel P, Lindholm B, Suliman ME (2008) Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta 393:114–118PubMedCrossRef
28.
Zurück zum Zitat Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef
29.
Zurück zum Zitat Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed
30.
Zurück zum Zitat Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMed Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMed
31.
Zurück zum Zitat Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMed Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMed
32.
Zurück zum Zitat Vosse D, Landewe R, Garnero P, van der Heijde D, van der Linden S, Geusens P (2008) Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in subjects with ankylosing spondylitis. Rheumatology (Oxford) 47:1219–1222CrossRef Vosse D, Landewe R, Garnero P, van der Heijde D, van der Linden S, Geusens P (2008) Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in subjects with ankylosing spondylitis. Rheumatology (Oxford) 47:1219–1222CrossRef
33.
Zurück zum Zitat Selmeci L, Seres L, Soós P, Székely M, Acsády G (2008) Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma. Acta Physiol Hung 95:209–218PubMedCrossRef Selmeci L, Seres L, Soós P, Székely M, Acsády G (2008) Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma. Acta Physiol Hung 95:209–218PubMedCrossRef
34.
Zurück zum Zitat Antus B, Harnasi G, Drozdovszky O, Barta I (2014) Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde. Respirology 19:74–79PubMedCrossRef Antus B, Harnasi G, Drozdovszky O, Barta I (2014) Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde. Respirology 19:74–79PubMedCrossRef
35.
Zurück zum Zitat Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD (2001) Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med 31:139–152PubMedCrossRef Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD (2001) Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med 31:139–152PubMedCrossRef
36.
Zurück zum Zitat Taylan A, Sari I, Akinci B, Bilge S, Kozaci D, Akar S, Colak A, Yalcin H, Gunay N, Akkoc N (2012) Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of subjects with ankylosing spondylitis. BMC Musculoskelet Disord 13:191PubMedCentralPubMedCrossRef Taylan A, Sari I, Akinci B, Bilge S, Kozaci D, Akar S, Colak A, Yalcin H, Gunay N, Akkoc N (2012) Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of subjects with ankylosing spondylitis. BMC Musculoskelet Disord 13:191PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Kaya A, Ozgocmen S, Kamanli A, Ardicoglu O (2009) Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med Princ Pract 18:470–476PubMedCrossRef Kaya A, Ozgocmen S, Kamanli A, Ardicoglu O (2009) Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med Princ Pract 18:470–476PubMedCrossRef
38.
Zurück zum Zitat Grazio S, Kusić Z, Cvijetić S, Grubišić F, Balenović A, Nemčić T, Matijević-Mikelić V, Punda M, Sieper J (2012) Relationship of bone mineral density with disease activity and functional ability in subjects with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 32:2801–2808PubMedCrossRef Grazio S, Kusić Z, Cvijetić S, Grubišić F, Balenović A, Nemčić T, Matijević-Mikelić V, Punda M, Sieper J (2012) Relationship of bone mineral density with disease activity and functional ability in subjects with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 32:2801–2808PubMedCrossRef
39.
Zurück zum Zitat Klingberg E, Lorentzon M, Mellström D, Geijer M, Göthlin J, Hilme E, Hedberg M, Carlsten H, Forsblad-d’Elia H (2012) Osteoporosis in ankylosing spondylitis prevalence, risk factors and methods of assessment. Arthritis Res Ther 14:R108PubMedCentralPubMedCrossRef Klingberg E, Lorentzon M, Mellström D, Geijer M, Göthlin J, Hilme E, Hedberg M, Carlsten H, Forsblad-d’Elia H (2012) Osteoporosis in ankylosing spondylitis prevalence, risk factors and methods of assessment. Arthritis Res Ther 14:R108PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Arends S, Spoorenberg A, Bruyn GA, Houtman PM, Leijsma MK, Kallenberg CG, Brouwer E, van der Veer E (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis subjects with active disease: a cross-sectional analysis. Osteoporosis Int 22:1431–1439CrossRef Arends S, Spoorenberg A, Bruyn GA, Houtman PM, Leijsma MK, Kallenberg CG, Brouwer E, van der Veer E (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis subjects with active disease: a cross-sectional analysis. Osteoporosis Int 22:1431–1439CrossRef
41.
Zurück zum Zitat Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R, Stefan S, Tamas MM, Bolosiu HD, Collantes-Estévez E (2011) Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30:691–695PubMedCrossRef Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R, Stefan S, Tamas MM, Bolosiu HD, Collantes-Estévez E (2011) Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30:691–695PubMedCrossRef
42.
Zurück zum Zitat Hyeon S, Lee H, Yang Y, Jeong W (2013) Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radic Biol Med 65:789–799PubMedCrossRef Hyeon S, Lee H, Yang Y, Jeong W (2013) Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radic Biol Med 65:789–799PubMedCrossRef
43.
Zurück zum Zitat Mazière C, Savitsky V, Galmiche A, Gomila C, Massy Z, Mazière JC (2010) Oxidized low density lipoprotein inhibits phosphate signaling and phosphate-induced mineralization in osteoblasts. Involvement of oxidative stress. Biochim Biophys Acta 1802:1013–1019PubMedCrossRef Mazière C, Savitsky V, Galmiche A, Gomila C, Massy Z, Mazière JC (2010) Oxidized low density lipoprotein inhibits phosphate signaling and phosphate-induced mineralization in osteoblasts. Involvement of oxidative stress. Biochim Biophys Acta 1802:1013–1019PubMedCrossRef
44.
Zurück zum Zitat Fatokun AA, Stone TW, Smith RA (2008) Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur J Pharmacol 587:35–41PubMedCrossRef Fatokun AA, Stone TW, Smith RA (2008) Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. Eur J Pharmacol 587:35–41PubMedCrossRef
45.
Zurück zum Zitat Karkucak M, Capkin E, Alver A, Akyuz A, Kiris A, Ak E, Topbas M, Tosun M (2010) The effect of anti-TNF agent on oxidation status in subjects with ankylosing spondylitis. Clin Rheumatol 29:303–307PubMedCrossRef Karkucak M, Capkin E, Alver A, Akyuz A, Kiris A, Ak E, Topbas M, Tosun M (2010) The effect of anti-TNF agent on oxidation status in subjects with ankylosing spondylitis. Clin Rheumatol 29:303–307PubMedCrossRef
Metadaten
Titel
The Relationship of Bone Mineral Density to Oxidant/Antioxidant Status and Inflammatory and Bone Turnover Markers in a Multicenter Cross-Sectional Study of Young Men with Ankylosing Spondylitis
verfasst von
Le Wang
Liangbin Gao
Dan Jin
Peng Wang
Bo Yang
Wen Deng
Zhongyu Xie
Yong Tang
Yanfeng Wu
Huiyong Shen
Publikationsdatum
01.07.2015
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 1/2015
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0001-x

Weitere Artikel der Ausgabe 1/2015

Calcified Tissue International 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.